COR Stock: Cencora, Inc. Stock Price, Analysis & Insights
Get live cor stock price $368.52, comprehensive Cencora, Inc. stock analysis, charts, news, and expert forecast. Real-time cor stock data and investment insights.
Loading chart...
Company Overview
Cencora, Inc. sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The company also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; and pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. The company's International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; and distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers and hospitals primarily in Europe. This segment also provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.
Company Information
- CEO
- Robert P. Mauch PharmD
- Sector
- Healthcare
- Industry
- Medical - Distribution
- Employees
- 42000
Contact Information
- Address
- 1 West First Avenue
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 46.0)
✓ Lower volatility stock (Beta: 0.64) may provide portfolio stability
Business Model & Strategy
Cencora, Inc. operates in the Medical - Distribution industry, focusing on medical services, pharmaceutical development, and healthcare delivery. As a mid-cap company, Cencora, Inc. benefits from scale advantages, market presence, and established operations. Under the leadership of CEO Robert P. Mauch PharmD, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Medical - Distribution model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
Cencora, Inc. competes in the Medical - Distribution within the broader Healthcare. With 71.4 billion in market capitalization, the company is positioned as a established player in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the New York Stock Exchange, Cencora, Inc. provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating Cencora, Inc. should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Cencora, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Cencora, Inc.
- ⚠Investors should consider how Cencora, Inc. fits within their overall portfolio allocation
- ⚠Premium valuation (P/E: 46.0) requires strong growth to justify
Market Cap
71.45B
P/E Ratio
45.95
Beta
0.64
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 71.45B market capitalization
- Trading Volume: 1.00M shares traded today
- Price Range: 52-week range of $223.92 - $377.54
- Exchange: Listed on New York Stock Exchange
Financial Metrics
Market Analysis for Cencora, Inc.
Cencora, Inc. (COR) operates in the Medical - Distribution industry within the Healthcare sector. With a current market capitalization of 71.45B, the company represents a significant player in its market. The stock is currently trading at $368.52 with a negativedaily change of 1.66%.
The company's 42000 employee base and presence on the New York Stock Exchangeexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of 45.95, beta of 0.64, and 52-week price range from $223.92 to $377.54when evaluating investment opportunities.
Why Invest in Cencora, Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (New York Stock Exchange)
- • Experienced leadership under Robert P. Mauch PharmD
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.